🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: 28-day drospirenone oral contraceptive

Found 18 matching trials

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

PHASE3

The objectives of this study were to evaluate the efficacy and safety of dr...

Status

Completed

Location

Multiple Locations

Start Date

2003-01

Trial ID

NCT00656981

Treatments Being Tested

YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)Placebo

Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)

PHASE3

The primary purpose of this study is to assess contraceptive efficacy, vagi...

Status

Completed

Location

Multiple Locations

Start Date

2006-05-01

Trial ID

NCT00511199

Treatments Being Tested

NOMAC-E2 DRSP-EE

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

PHASE3

Oral contraceptives are known to improve menstrual cycles and symptoms in P...

Status

Completed

Location

University of Rochester Medical Center

Start Date

2006-01

Trial ID

NCT00283816

Treatments Being Tested

Metformin Oral Contraceptive Pill Lifestyle Management Program Quality of Life Questionnaire Oral Glucose Tolerance Test Blood work Abdominal Ultra Sound Dual-energy x-ray absorptiometry (DEXA scan)placebo

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

PHASE4

We investigate parameters of hemocoagulation and lipoperoxidation in women ...

Status

Unknown

Location

Tyumen State Medical Academy

Start Date

2013-12

Trial ID

NCT02027337

Treatments Being Tested

20 mcg ethinylestradiol /3 mg drospirenone 20 mcg ethinylestradiol/3 mg drospirenone and Selmevit 30 mcg ethinylestradiol/3 mg drospirenone 30 mcg ethinylestradiol/3 mg drospirenone and Selmevit 35 mcg ethinylestradiol/2 mg cyproterone 35 mcg ethinylestradiol/2 mg cyproterone and Selmevit

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

PHASE3

The objectives of this study were to evaluate the efficacy and safety of dr...

Status

Completed

Location

Multiple Locations

Start Date

2003-01

Trial ID

NCT00651469

Treatments Being Tested

YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)Placebo

Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

This is a single-center, non-randomized, open-label clinical study to inves...

Status

Completed

Location

Guangdong Women and Children Health Hospital

Start Date

2023-02-01

Trial ID

NCT05872425

Treatments Being Tested

DingKunDan(GuangYuYuan)Drospirenone and Ethinylestradiol Tablets (Ⅱ)

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

PHASE1

This study is being conducted to evaluate the impact of a 28-day oral contr...

Status

Completed

Location

Teva Investigational Site 10119

Start Date

2011-01-31

Trial ID

NCT01291004

Treatments Being Tested

Desogestrel/ethinyl estradiol and ethinyl estradiol 28-day drospirenone oral contraceptive 28-day levonorgestrel oral contraceptive

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

PHASE2

In this study a comparison was made on the influence of missing pills on fo...

Status

Completed

Location

Multiple Locations

Start Date

2004-05

Trial ID

NCT00673686

Treatments Being Tested

YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)Yasminelle (SH T 00186 D)

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

PHASE4

The objective of this study was to investigate the impact of the oral contr...

Status

Completed

Location

Multiple Locations

Start Date

2003-06

Trial ID

NCT00651846

Treatments Being Tested

Yasmin (DRSP 3mg/EE 0.03 mg)Microgynon (LNG 0.15 mg/EE 0.03 mg)

To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

PHASE3

The objective of this study is to investigate the safety and efficacy of (0...

Status

Withdrawn

Location

Multiple Locations

Start Date

2016-01

Trial ID

NCT02617537

Treatments Being Tested

EE20/DRSP(YAZ,BAY86-5300)Placebo

Previous Next